ECG Equipment And Management Systems Market (2026 - 2033)

ECG Equipment and Management Systems Market Summary

The global ECG equipment and management systems market size was valued at USD 8.4 billion in 2025 and is projected to grow from USD 8.9 billion in 2026 to USD 14.5 billion by 2033, at a CAGR of 7.1% from 2026 to 2033. North America dominated the market, accounting for the revenue share of approximately 45.0% in 2025. The growing prevalence of cardiac arrhythmia and increasing demand for ambulatory monitoring devices are expected to drive the market.

The global market is experiencing steady growth, driven by the rapidly aging population, the rising prevalence of cardiovascular diseases (CVDs), and ongoing technological advancements in cardiac diagnostics. Older adults are at a significantly higher risk of developing arrhythmias, coronary artery disease, heart failure, and other cardiac conditions that require routine electrocardiographic monitoring. According to the World Health Organization (WHO), one in six people globally will be aged 60 years or older by 2030, while the population in this age group is projected to increase from 1.4 billion in 2030 to 2.1 billion by 2050. Similarly, Eurostat reported that individuals aged 65 years and above accounted for approximately 22% of the European Union's population in 2025, highlighting the growing need for cardiac monitoring solutions.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The increasing burden of chronic diseases is further accelerating market demand. According to the American Heart Association's 2025 Heart Disease and Stroke Statistics Update, nearly 48.6% of U.S. adults are living with some form of cardiovascular disease, driving the need for advanced ECG equipment, ambulatory monitoring devices, and integrated cardiac management platforms.

Technological innovation is also transforming the market. Healthcare providers are increasingly transitioning from conventional paper-based ECG workflows to digital, cloud-connected ECG management systems that enable seamless data sharing, remote monitoring, and integration with hospital information systems. Advances in artificial intelligence, wireless connectivity, and interoperable cardiovascular information systems (CVIS) are improving diagnostic accuracy and clinical workflow efficiency. Reflecting this trend, in November 2025, GE HealthCare and AliveCor implemented the world's first clinical integration of the MUSE Cardiology Information System with the KardiaMobile 6L ECG device at Hannover Medical School, enabling clinicians to securely access and analyze remotely acquired ECG data within existing hospital workflows and supporting faster clinical decision-making.

Analyst Perspective

The ECG equipment and management systems market is growing as healthcare providers increasingly prioritize early detection and continuous monitoring of cardiovascular diseases. Rising cases of heart disorders, an aging population, and greater adoption of preventive healthcare are driving demand for advanced ECG devices and integrated data management platforms. Hospitals, diagnostic centers, and outpatient facilities are investing in systems that improve workflow efficiency, enable centralized storage of ECG records, and support faster clinical decision-making. The integration of cloud computing, artificial intelligence, and remote monitoring technologies is further enhancing diagnostic accuracy and patient management. Companies with strong expertise in cardiac diagnostics, interoperable software platforms, and connected healthcare solutions are likely to strengthen their market position.

Type Insights

The resting ECG system segment led the market with the largest revenue share of more than 55.0% in 2025. This segment's growth can be attributed to improved clinical accuracy resulting from new product launches, advanced data analysis tools, and various technological advancements that enhance patient care and ensure accurate diagnosis. For example, in 2025, SCHILLER continued to expand the deployment of its CARDIOVIT AT-102 G2 resting ECG system. This system features automated ECG interpretation, EMR connectivity, and high-quality 12-lead resting ECG acquisition, making it an essential tool for hospitals and diagnostic centers.

The ECG management systems segment is expected to grow at the fastest CAGR during the forecast period. This growth is driven by the increasing demand for centralized ECG data management, seamless integration with electronic health records (EHRs), and AI-enabled clinical decision support. These systems enhance workflow efficiency, allow remote access to patient ECG records, and improve diagnostic accuracy across healthcare settings. For instance, in May 2025, HeartSciences launched its MyoVista Insights platform, a cloud-native ECG management system that integrates AI-powered ECG algorithms and streamlines ECG workflows for healthcare providers.

End Use Insights

The hospitals and clinics segment dominated the market with the largest revenue share of more than 40.0% in 2025. This growth is due to the increasing prevalence of cardiac arrhythmias and the rising adoption of Holter devices in hospitals.

The ambulatory facilities segment is expected to grow at a notable CAGR during the forecast period. Technological advancements, shifting interest toward ambulatory centers for treatment, and the availability of advanced portable devices, such as ECG equipment and ambulatory ECG management systems, are driving growth in the segment.

As these devices facilitate the immediate transfer of data on outpatient procedures, demand for them is increasing in ambulatory centers for accurate assessment of cardiac arrhythmias.

Regional Insights

The North America ECG equipment and management systems market held the largest revenue share of approximately 45.0% in 2025. This can be attributed to the increasing geriatric population and the rise in lifestyle-related diseases. As of 2025, cardiovascular disease remained the leading cause of death in the U.S., with the latest CDC data reporting 919,032 deaths attributed to this condition, an average of one person dying every 34 seconds. The growing adoption of AI-enabled ECG equipment, remote cardiac monitoring systems, and wearable ECG devices is expected to further support market growth across North America.

To learn more about this report, Download Free Sample Report

Asia Pacific ECG Equipment and Management Systems Market Trends

The ECG equipment and management systems market in the Asia Pacific is projected to grow at the fastest CAGR over the forecast period. This growth is driven by the rising prevalence of cardiovascular diseases, the expansion of healthcare infrastructure, and the increasing adoption of digital healthcare technologies. In addition, government investments in healthcare modernization and the rising demand for remote cardiac monitoring are anticipated to enhance access to advanced diagnostic systems in the region. For example, in May 2025, Nihon Kohden launched its latest integrated diagnostic cardiology and patient-monitoring solutions for the Asia-Pacific market, designed to enhance ECG management capabilities by improving connectivity and clinical workflow integration.

Key ECG Equipment and Management Systems Company Insights

The ECG equipment and management systems industry features a range of global, regional, and local players, making it a competitive market. The world’s leading companies are using partnerships, collaborations, acquisitions, mergers, and agreements as strategies to withstand the intense competition and increase their market share. ECG equipment and management systems product manufacturers are investing heavily in product enhancements and new product development.

Key ECG Equipment and Management Systems Companies

The following key companies have been profiled for this study on the ECG equipment and management systems market.

• Baxter International Inc.

• CardioComm Solutions, Inc.

• Compumed Inc.

• Drägerwerk AG & Co. KGaA

• GE HealthCare Technologies Inc.

• Koninklijke Philips N.V.

• McKesson Corporation

• Medical ECONET GmbH

• Meditech Equipment Co., Ltd.

• Nihon Kohden Corporation

• SCHILLER AG

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

• Spacelabs Healthcare

• ZOLL Medical Corporation

Recent Developments

• In April 2025, GE HealthCare partnered with FPT Corporation to accelerate AI-enabled healthcare solutions, including diagnostic cardiology and ECG workflow management systems, enhancing digital healthcare transformation globally.

• In April 2025, Koninklijke Philips N.V. introduced the AI-enabled Cardiologs ECG Analysis Portfolio on its HealthSuite platform, enhancing automated ECG interpretation and clinical workflow efficiency for cardiology departments.

Global ECG Equipment and Management Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ECG equipment and management systems market report based on type, end use, and region:

• Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Holter Monitors

  • Resting ECG System

  • Stress ECG Monitors

  • Event Monitoring Systems

  • ECG Management Systems

• End-use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hospitals & Clinics

  • Ambulatory Facilities

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa